From the American Diabetes Association news roomFebruary 24, 2014The American Diabetes Association and YMCA of the USA (Y-USA), in collaboration with the American Medical Association (AMA), released important new research today examining HR 962/S 452, the Medicare Diabetes Prevention Act (MDPA). The study, Estimated Federal Impact of the Medicare Diabetes Prevention Act, conducted by Avalere Health, was commissioned by the three organizations to identify the federal government savings or cost burden of the legislation using methods similar to those of the Congressional Budget Office (CBO). The research estimates the legislation would reduce federal spending by $1.3 billion over the 10-year budget window (2015-2024) and also reduce the incidence of diabetes among seniors.“Coverage of diabetes prevention programs under Medicare will advance the fiscal health of our nation by reducing overall health care spending on diabetes,” said John Anderson, MD, immediate past president, Medicine & Science, American Diabetes Association. “With the cost and prevalence of diabetes reaching unprecedented levels, there has never been a more critical time for Congress to support cost-effective, evidence-based programs that will improve the lives and health of America’s seniors.”Read the full article.